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Background: In 2008–2009 the South African National Tuberculosis (TB) Program (NTP) implemented a national
pilot project, the TB Tracer Project, aiming to decrease default rates and improve patient outcomes. The current
study aimed to inform the NTP by describing the knowledge, attitudes, and practices of TB program personnel
involved with tracing activities.
Methods: A self-administered written questionnaire was sent to TB staff, managers and tracer team leaders to
assess basic TB knowledge, attitudes and practices. Descriptive statistics were used to summarize results and the
chi-squared statistic was used to compare responses of staff at facilities that participated in the TB Tracer Project
(tracer) and those that followed standard NTP care (non-tracer).
Results: Of 560 total questionnaires distributed, 270 were completed and returned (response rate 48%). Total TB
knowledge ranged from 70.8-86.3% correct across all response groups. However, just over half (range 50–59.3%) of
each respondent group was able to correctly identify the four components of a DOT encounter. A patient no
longer feeling sick was cited by 72.1% of respondents as the reason patients fail to adhere to treatment. Tracer
teams were viewed as an effective means to get patients to return to treatment by 96.3% of health facility level
respondents. Tracer team leaders reported concerns including lack of logistical support (41.7%), insufficient physical
safety precautions (41.7%), and inadequate protection from contracting TB (39.1%). Upon patients returning to
treatment at the clinic, facilities included in the TB Tracer Project were significantly more likely to discuss alternate
DOTS arrangements than non-tracer facilities (79.2 vs. 66.4%, p = 0.03).
Conclusions: This study identified key components of knowledge, attitudes, and practices regarding TB patient
tracing activities in South Africa. Educating patients on the essential need to complete treatment irrespective of
clinical symptoms may help improve treatment adherence. Future scale-up and integration of TB tracing activities
as part of standard TB management should include provisions for standardized training of personnel on the critical
elements of DOTS, and for ensuring appropriate supervision, logistical support, and physical safety and TB
transmission protection of tracing teams.
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Tuberculosis (TB) is a curable disease, yet 8.8 million
persons worldwide are newly infected and 1.45 million
persons die each year from TB [1]. Adherence to a
standard course of treatment is paramount to achieving
an effective cure of TB disease. Failure to cure persons
with infectious TB disease promotes drug-resistant
strains, increases patient risk for morbidity and mortality,
and facilitates continued community transmission [2-5].
However, despite widespread adoption of the directly-
observed therapy short-course (DOTS) strategy for over a
decade, treatment adherence and default from treatment
continue to be a primary challenge in TB control.
Home visits and community outreach are often
employed as methods to optimize treatment adherence
among TB patients. Previous research has consistently
demonstrated the effectiveness of such patient tracing
activities in returning patients to care and improving
final treatment outcomes [6-11]. However, the ability to
conduct these activities may be constrained by limita-
tions in human and logistic resources, particularly in
resource-limited settings with a high TB burden.
In South Africa, where the TB burden is considered
the 3rd highest in the world [1], DOTS coverage is
reported to be 100% [12]; yet, treatment success rates re-
main below global targets and the burden of drug-
resistant TB strains continues to escalate [1].
In 2008–2009, the South African National TB Program
(NTP) implemented a national pilot project, the TB
Tracer Project, aiming to decrease default rates and im-
prove patient outcomes, by creating teams dedicated to
tracing TB patients [13]. The intervention has been de-
scribed previously, but in brief, teams of health care
workers were employed at health facilities to trace TB
patients who had interrupted treatment or had missed
scheduled follow up appointments for monitoring spu-
tum status [14]. The project was implemented as a NTP
programmatic intervention, therefore tracer team activ-
ities varied by sub-district. A recent evaluation utilizing
data from routine national TB surveillance demonstrated
that sub-districts that participated in the project (tracer)
had significantly greater decreases in patient default
rates and significantly greater increases in treatment suc-
cess rates over the project period, compared to sub-
districts that were not part of the project (non-tracer)
(default rate decline 2.8% tracer vs. 0.7% non-tracer; suc-
cess rate increase 2.6% tracer vs. 0.8% non-tracer)
[13,14]. However, further examination is needed to bet-
ter understand activities utilized for tracing patients and
identify reasons that may help explain the differences be-
tween tracer and non-tracer sites.
The current study aimed to describe the knowledge,
attitudes, and practices of health care and TB program
personnel involved with tracing activities and to evaluatethe differences between health facilities that participated
in the TB Tracer Project (tracer) and health facilities that




A survey was conducted in 2010 to include all districts
that had participated in the TB Tracer Project (2008–
2009). In brief, districts were selected for the Project by
provincial and national TB program managers based on
designation as having a high burden of TB disease and/or
high rates of treatment default; the TB managers at each
district selected sub-districts for inclusion in the Tracer
Project. There were 21 district and 65 sub-districts that
participated in the TB Tracer Project. Within each sub-
district, a convenience sample of health facilities was se-
lected to participate.
For the current evaluation, self-administered question-
naires were distributed to five respondent groups involved
in TB control at the district and sub-district level: (1) dis-
trict TB program managers, (2) sub-district TB program
managers, (3) tracer facility TB managers, (4) non-tracer
facility TB managers, and (5) tracer team leaders. A 30%
random sample of health facilities that participated in the
project (tracer) and 30% random sample of health facilities
in the same sub-districts that did not participate in the
project (non-tracer) were also selected. The questionnaire
was sent to the TB manager at each selected facility. The
tracer team leaders (n = 72) were also sent questionnaires
for completion. Questionnaires for the survey were dis-
tributed and collected by TB personnel in each province.
Questionnaires were sent via mail to the tracer team
leaders with stamped return envelopes.
Questionnaires
Standardized questionnaires were sent to each provincial
TB office to distribute to the participating district and sub-
district offices and health facilities. Individuals that were in
a position to answer the questions (e.g., TB program man-
ager) and had been working during the TB Tracer Project
were asked to participate. The self-administered question-
naires aimed to assess basic TB knowledge, attitudes, and
practices of persons involved with TB management and
tracing TB patients. Basic demographic information was
collected from each respondent, including age, gender,
education, number of years working in TB, and TB-related
training. The questionnaires included a core set of ques-
tions across all participant groups, but were tailored to ad-
dress differing roles of each group.
Knowledge
A set of sixteen questions were used to assess basic TB
knowledge, including TB etiology, transmission, clinical
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and monitoring, and infection [15]. Questions were mul-
tiple choice, with the majority involving a single correct
answer. However, some of the questions required mul-
tiple answers (e.g., identifying all first line TB medica-
tions) to be considered correct.
Attitudes and perceptions
Questionnaires included items aiming to better under-
stand general perceptions about the usefulness of tracing
activities and key reasons for not routinely conducting tra-
cing activities as part of standard TB management. Partici-
pants were also asked open-ended questions to provide
their views on the primary reasons that TB patients failed
to adhere to TB treatment. Tracer team leaders were
asked specific multiple-choice and open-ended questions
about their experience during the project.
Practices
Participants were asked about program practices related
to the provision of TB treatment to patients, including
number of health care staff, clinic operating hours,
DOTS models available to patients, and approaches used
to trace patients.
Ethics
This evaluation was reviewed and approved by the Insti-
tutional Review Boards of the US and South African
Centers for Disease Control and Prevention and the
South African Medical Research Council. Written, in-
formed consent was obtained from all participants who
completed and returned the questionnaire.
Analysis
Descriptive statistics were used to summarize general TB
knowledge among each of the groups and for the total
sample. A TB knowledge summary score was calculated
by dividing the sum of the number of correct responses
by the total number of questions and multiplying by 100
to reflect a percentage. Knowledge summary scores
were compared between tracer and non-tracer TB health
facility managers.
Attitudes, perceptions, overall acceptability, and prac-
tices of the TB Tracer Project were summarized using
descriptive statistics overall and for each of the five re-
spondent groups: district TB Managers, sub-district TB
managers, health facility TB managers (both from tracer
and non-tracer sites), and TB Tracer team leaders. For
characteristics and questions that were asked to both
tracer and non-tracer facility participants, comparisons
were conducted using chi-squared test and Student’s
t-test. Significance was defined at a p-value of less than
or equal to 0.05. All analyses were conducted using Stata
11.0 (College Station, Texas).Results
Of 560 total questionnaires distributed, 270 were com-
pleted and returned (response rate 48%; Figure 1). Of
the 270 returned, 10 were from TB managers at the dis-
trict TB office, 27 were from sub-district TB personnel,
120 from tracer TB managers and 113 from non-tracer
TB managers. Response rates were similar among tracer
and non-tracer TB managers at health facilities (48 vs.
46%, respectively). An additional 25 questionnaires were
returned from individual TB tracer team leaders, yield-
ing a 35% response rate (25/72). A total of 295 question-
naires were available for the current study analysis.
Respondent and program characteristics
Overall, the average age of questionnaire respondents
was 47.2 years (SD 10.2);, tracer team leaders tended to
be older (mean 63.6 years, SD 6.5) than other respond-
ent groups (Table 1). Most respondents (92.2%) were fe-
male, had a tertiary education at a college or university,
and were currently or previously employed as nurses in
the health facilities during the TB Tracer Project. Across
all response groups, the mean number of years working
with TB was 9.8 (SD 8.17). The majority had received
clinical training on TB disease (83.1%; 245/295) and
57.0% had attended training on DOTS (168/295).
The health facilities included in this analysis reported
an average of 5.1 persons (SD 9.5) designated for the
care and treatment of TB patients at the time of the
Tracer Project. On average, health facilities were avail-
able 5.3 days (SD 1.0) per week to diagnose and manage
TB patients (Table 2). Almost all (94.4%) health facilities
offered community based DOTS (219/232) and reported
being open for DOTS and clinic visits for an average of
9.4 hours (SD 3.4) per day. The number of days available
to provide DOTS to patients each week was slightly but
significantly greater on average among tracer sites com-
pared to non-tracer sites [5.5 (SD 0.86) vs. 5.2 (SD 1.2),
p = 0.04].
TB Knowledge
Total TB knowledge was similar across all respondent
groups, ranging from 70.8-86.3% responses correct
(Table 3). Just over half of each respondent group (range
50–59.3%) was able to correctly identify the four compo-
nents of a DOT encounter.
Attitudes and perceptions
When queried, the reasons most frequently identified for
non-adherence to treatment were that patients no longer
felt sick (72.1%), personal or cultural beliefs (30.6%), side
effects of treatment (30.6%), and fear of stigma (29.8%)
(Table 4). Tracer teams were viewed as an effective means
to get patients to return to treatment by 96.3% (105/109)




















270 (48%)   
Figure 1 Distribution and response rates among TB managers at health facilities and program offices included in the study. *25 of 72
Tracer team leaders returned completed questionnaires.
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primary reason for not routinely tracing patients (23/66;
30.3% of respondents). The tracer team leaders also
expressed concerns, with 41.7% (10/25) reporting that they
did not feel they had sufficient logistical support and 8.3%
(2/24) not feeling as though they had adequate supervision
and direction from the district or provincial TB managers.
Over one-third of team leaders did not feel they had an






Age, years mean (SD) 47.9 (SD 6.8) 44.5
Gender
Female 7 (70) 22
Male 3 (30) 5
Highest level of education
Primary 0
Secondary 0 2
College 3 (30) 12
University 7 (70) 13
Professional Occupation
Physician 0
Nurse 10 (100) 27
Community Health Worker 0
Retired Nurse 0
Number of years working with TB patients, mean (SD) 14.7 (SD 8.3) 9.3
Training Course
Clinical training on TB disease 10 (100) 26
Training on reading Chest x-rays 3 (30) 3
Training on DOTS 9 (90) 19
Training on sputum microscopy 6 (60) 16
Other trainings 5 (50) 10
Percents reflect proportion that answered the question.
SD standard deviation.
Values represent number and percentage unless otherwise indicated.necessary to travel while tracing TB patients (10/24;
41.7%) and felt inadequately protected from contracting
TB from patients (9/25; 39.1%).
Practices
Almost all (95.5%) respondents from the non-tracer
health facilities reported that they routinely conduct ac-
tivities to track and trace patients who have not adhered











(%) n (%) n (%) n (%) n(%)
(SD 8.1) 46.0 (SD 9.3) 45.4 (SD 9.2) 63.6 (SD 6.5) 47.20 (SD 10.2)
(81.5) 113 (94.2) 105 (92.9) 25 (100) 272 (92.2)
(18.5) 7 (5.8) 8 (7.1) 0 23 (7.8)
0 1 (.8) 0 0 1 (.3)
(7.4) 12 (10) 15 (13.4) 10 (40) 39 (13.3)
(44.4) 68 (56.7) 59 (52.7) 7 (28) 149 (50.7)
(48.2) 39 (32.5) 38 (33.9) 8 (32) 105 (35.7)
0 0 0 0 0
(100) 117 (97.5) 108 (95.6) 5 (20) 267 (90.5)
0 3 (2.5) 4 (3.5) 1 (4) 8 (2.7)
0 0 0 19 (76) 19 (6.4)
(SD 6.0) 9.6 (SD 7.8) 8.9 (7.6) 13.2 (12.4) 9.8 (SD 8.2)
(96.3) 100 (83.3) 88 (77.9) 21 (84) 245 (83.1)
(11.1) 4 (3.3) 3 (2.7) 4 (16) 17 (5.8)
(70.4) 65 (54.2) 60 (53.1) 15 (60) 168 (57.0)
(59.3) 34 (28.3) 29 (25.7) 12 (48) 97 (32.9)
(37.0) 19 (15.8) 20 (17.7) 7 (28) 61 (20.7)







Persons designated for the care and treatment of TB patients 5.1 (9.5) 5.8 (11.8) 4.4 (16.2) 0.26
Days per week the clinic open to provide TB diagnosis and clinic visits 5.3 (1.0) 5.5 (0.87) 5.1 (1.2) 0.12
Days per week the clinic open to provide DOTS to TB patients 5.3 (1.1) 5.5 (0.86) 5.2 (1.2) 0.04
Hours of operation per day the clinic open to provide DOTS to TB patients 9.4 (3.4) 8.9 (3.4) 10.0 (5.5) 0.08
SD standard deviation.
*p-value based on t-test comparison of tracer vs. non-tracer facilities.
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ing of tracing activities, with the majority seeking out
the patient within 6 days of missing a treatment dose.
Tracing activities in both tracer and non-tracer facilities
involved home and workplace visits for all patients; there
were no significant differences observed between the
two groups. A significantly greater proportion of non-
tracer health facilities compared to tracer health facilities
reported using phone calls to trace patients that missed
a treatment dose or a clinic visit (p < 0.001). More than
95% of TB tracer team leaders reported that once the




What causes TB? 9 (90
How is TB spread? 10 (10
What part of the body is the most common site for TB disease? 9 (90
What is the strongest known risk factor for the development of
TB disease?
9 (90
What are the symptoms of pulmonary TB disease? 6 (60
How is active TB disease diagnosed? 9 (90
If a person with HIV has a negative sputum smear, what
laboratory technique is particularly useful to determine
whether a patient with HIV has TB?
10 (10
What is the standard duration of treatment for TB that is
drug-susceptible?
10 (10
Which four drugs are recommended for the initial treatment of
TB disease?
10 (10
If someone with active TB stops taking their medicines before they
have completed treatment, what are the potential consequences?
10 (50
What is DOTS? 10 (90
What are four components of DOT encounter? 10 (50
Which TB patients should be given DOTS? 10 (10
How long should a TB patient be provided DOTS 10 (90
What is multidrug resistant TB? 10 (90
What precautions should a health care worker take when visiting
the home or interacting with a TB patient who may be infectious?
10 (90
Total knowledge score (%) 92 (86
*p-value for comparison between tracer and non-tracer facilities.
Values reflect number and percentage correct.appointment (DOT or sputum appointment), they ask
the patient the reason for missing the appointment and
they reeducate both the patient and the family on the
importance of treatment adherence. Upon returning to
treatment at the clinic, tracer facilities were significantly
more likely to discuss alternate DOTS arrangements
than non-tracer facilities (79.2 vs. 66.4%, p = 0.03).
Discussion
This study examined the knowledge, attitudes and prac-
tices utilized to trace TB patients in South Africa, both











p-value*n (%) n (%) n (%) n (%)
) 26 (96.3) 23 (92.0) 111 (92.5) 102 (90.3) 0.54
0) 26 (96.3) 24 (96.0) 118 (98.3) 110 (97.3) 0.6
) 27 (100.0) 23 (92.0) 118 (98.3) 102 (90.3) 0.17
) 20 (74.1) 11 (44.0) 49 (40.8) 61 (54.0) 0.05
) 12 (44.4) 15 (60.0) 59 (49.2) 53 (46.9) 0.73
) 27 (100.0) 25 (100.0) 116 (96.7) 108 (95.6) 0.67
0) 24 (88.9) 18 (72.0) 96 (80.0) 95 (84.1) 0.42
0) 27 (100.0) 23 (92.0) 115 (95.8) 106 (93.8) 0.48
0) 26 (96.3) 20 (80.0) 102 (85.0) 99 (87.6) 0.56
) 11 (40.7) 9 (36.0) 50 (41.7) 47 (41.6) 0.99
) 26 (96.3) 23 (92.0) 112 (93.3) 107 (94.7) 0.66
) 16 (59.3) 13 (52.0) 65 (54.2) 58 (51.3) 0.66
0) 26 (96.3) 21 (84.0) 115 (95.8) 108 (95.6) 0.92
) 25 (92.6) 18 (72.0) 110 (91.7) 108 (95.6) 0.22
) 24 (88.9) 13 (52.0) 68 (56.7) 62 (54.9) 0.78
) 17 (63.0) 4 (16.0) 20 (16.7) 33 (29.2) 0.02
.30) 360 (83.3) 283 (70.8) 1424 (74.2) 1359 (75.8) 0.27
Table 4 Perceptions by personnel involved in
management and treatment of TB on why patients fail to
adhere to TB treatment (n = 258)
n (%)
In your experience with TB patients, what is the most
common reason that patients do not adhere to treatment?
Patients no longer feel sick 186 (72.1)
Personal or cultural beliefs 81 (31.4)
Side effects of treatment 79 (30.6)
Fear of stigma 77 (29.8)
Lack of knowledge 63 (27.0)
Lack of access to health care 66 (25.6)
Lack of motivation 47 (18.2)
Feelings of depression or hopelessness
about TB disease
37 (14.3)
Poor relationship with health care workers 35 (13.6)
Lack skills to follow medication instructions 28 (10.9)
Language barrier with health care worker 17 (6.6)
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tracing as part of standard care within the NTP. This
study elucidated specific concerns and aspects that
should be considered when integrating tracing activities
into routine TB care. Overall, study participants dem-
onstrated a high level of knowledge on core questions
regarding the etiology, diagnosis, treatment, and pre-
vention of TB. There was a similar level of overall
knowledge between tracer and non-tracer facilities,
suggesting that basic TB knowledge did not factor into
previously reported differences on the impact of tracing
activities [13,14].
The tracer teams were regarded as an effective method
for returning patients to treatment, even with the chal-
lenges reported by the tracer teams; these findings are
similar to previous research [16]. Practices employed by
tracer teams focused on returning patients to treatment,
patient education and the development of future treat-
ment adherence plans. Non-tracer facilities also reported
that they conduct some tracing activities, however, we
were not able to assess the frequency of patient home
and workplace visits by tracer facilities teams compared
to non-tracers. A greater proportion of non-tracer
health facilities reported using phone calls to trace pa-
tients and non-tracer facilities were more likely to con-
tact the family members of patients than tracer
facilities teams. Non-tracer facilities identified lack of
human resources as the top reason why they do not
routinely trace patients.
While respondents averaged 9.8 years of experience
working in TB, it is of concern that just over half of each
respondent group (range 50–59.3%) was able to cor-
rectly identify the four components of a DOT encounter,namely, verifying the medication, watching the patient
take pills, checking for side effects, and documenting the
visit. However, the lack of understanding of DOT may
be due to only a fraction of respondents reporting hav-
ing formal training on DOTS (range 53.1-90%). Our
findings are similar to those reported from a survey of
private practitioners in Ethiopia, wherein only 39.3% had
satisfactory knowledge of DOTS [17]. The study also
reported that practitioners who had received training on
DOTS within the previous 2 years were over four times
more likely to have satisfactory knowledge on TB treat-
ment. These findings underscore the critical need to en-
sure that all personnel involved with TB treatment and
monitoring receive comprehensive training on TB care
and treatment.
When asked to identify reasons patients fail to adhere
to treatment, over two-thirds of respondents cited that
patients no longer feel sick, and over a quarter men-
tioned patient personal or cultural beliefs, side effects of
treatment, fear of stigma, lack of knowledge and lack of
access to health care. A review of research on patient
adherence revealed similar factors leading to non-
adherence and default, citing interpretations of illness
and wellness as a major factor wherein patients who feel
better no longer believe that they are ill and stop taking
their medication [16]. Investigators also pointed out that
knowledge and attitudes affect adherence, similar to re-
sponses expressed by TB personnel in the present study
of patient personal and cultural beliefs creating a barrier
to adherence. The findings from the current study, in
concert with previous research, highlight the need to
include patient education emphasizing the importance
of completing treatment to effectively cure TB disease
as part of standard practice for treating and tracing
TB patients.
Activities conducted upon return to the clinic are also
important in patient adherence and reuptake of treat-
ment after default. When a patient returns to the clinic,
personnel at tracer facilities were more likely to discuss
alternative DOTS arrangements with patients than non-
tracer facilities. It is possible that these encounters
assessed individual barriers to treatment adherence and
identified mutually-agreeable methods for providing TB
treatment to these patients, which would favor treatment
adherence and successful outcomes [10].
Of the tracer team leaders that returned question-
naires, the majority viewed their relationship with health
facility staff as very good or excellent, but they also
expressed some major concerns. Their concerns in-
cluded lack of logistical support and supervision and dir-
ection from the district or provincial TB managers. They
also expressed concerns over their personal safety, both
in terms of physical protection in the areas where they
were tracing patients and contracting TB from patients.
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provement of future tracing activities in South Africa
and other high burden countries.
Some limitations and biases exist in this study. This
study was based solely on qualitative and quantitative
data from questionnaires. The questionnaires were sent
retrospectively with an extended delay from the time of
program implementation making this study subject to
recall bias. It is possible that some respondents were no
longer in the same positions, and those that were may
have trouble recollecting activities conducted during the
TB Tracer Project. Reported activities may more accur-
ately represent current activities in the program, which
may have changed since the project period. However, it
is unlikely that the ability to recall information was sub-
stantially different between the different groups of re-
spondents. The overall response rate was very low,
subjecting our results to bias if respondents were dis-
tinctly different than persons that did not complete and
return the questionnaires. Our findings may therefore
not be representative of the total target population. Our
efforts to improve response rates included calling and
emailing districts and individuals to remind them to re-
turn the questionnaires. Many of the current district
staff were not involved at the time of the tracer project
and therefore didn’t send feedback and were not in-
cluded in the study. However, there was little variation
in response rates across the provinces that participated
in the evaluation. Additionally, it was not possible to
evaluate the success among tracer teams to get patients
to return to treatment or final patient outcomes, as no
information was collected prospectively to track patients
identified for tracing individually and the outcome of
tracing efforts. The differences revealed in this study be-
tween tracer and non-tracer sites are unlikely to have
made any substantial contribution to the greater im-
provements in treatment outcomes at tracer sites com-
pared to non-tracer sites during the TB Tracer Project
period [13,14].
Conclusions
Despite limitations, the current study presents a useful
assessment of core TB knowledge among TB program
and health facility staff and of practices utilized to in-
crease adherence among TB patients in South Africa.
Future studies and health interventions using TB patient
tracer teams should include ongoing TB practitioner and
tracer trainings. These should stress the need for in-
creased patient education that emphasizes the critical
importance of completing treatment irrespective of clin-
ical symptoms. A clear evaluation strategy prior to
implementation is also essential in order to accurately
understand the relationship of these factors to changes
in default and cure rates. Ongoing monitoring anddocumentation of the frequency of tracing activities
will also help to describe differences observed in pa-
tient treatment outcomes. These components are vital
to identify patient and programmatic factors that
may be instrumental in optimizing the success of TB
tracing activities.
The study also identified factors that must be consid-
ered to optimize the success of tracing activities, includ-
ing the need for ongoing TB staff education and
provisions to ensure physical and personal safety during
tracing. The challenges that tracer teams experienced in-
cluding poor logistical support and fear for safety need
to be carefully considered when planning for tracer out-
reach teams.
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